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ABSTRACT Crystals of a complex formed between ribonuclease A and d(pA)4 were grown and their structure
determined by a combination of multiple isomorphous replacement (MIR) and molecular replacement techniques. The
known structure of ribonuclease A in the correct orientation in the unit cell yielded a conventional crystallographic R
factor of 0.32 at 2.8 A resolution when refined as a rigid body. Difference Fourier syntheses permitted determination of
the disposition of the DNA in the unit cell. Refinement of both protein and DNA by constrained-restrained least
squares procedures resulted in an R factor of 0.22 at 2.5 A resolution. The structure of the crystalline complex is
comprised of four ordered oligomers of d(pA)4 associated with each molecule of RNAse. If the sites of interaction
between protein and d(pA)4 fragments are mapped on the surface of the protein, they describe an essentially continuous
path into and through the active site, across the surface of the enzyme and finally into the basic amino acid cluster on the
opposite side of the protein.
Felsenfeld and his colleagues showed that pancreatic ribo-
nuclease, because it binds single-stranded DNA preferen-
tially, is an effective DNA helix destabilizing, or unwind-
ing, protein (1). These studies were extended by Jensen
and von Hippel (2), and by Record et al. (3), who
demonstrated that RNAse binds to both double- and
single-stranded DNA, apparently by two distinctly dif-
ferent mechanisms, though both use predominantly elec-
trostatic interactions. They further showed that when
RNAse is bound to single-stranded DNA, it covers or
protects 8-12 bases along the polynucleotide chain; this
binding proceeds through' the formation of at least seven
ion pairs (2,3). The protection size predicted by the data
and the probable involvement of seven lysine and arginine
residues forming salt bridges to nucleotide phosphate
groups are not readily explained by the current concept of
the enzyme's nucleic acid binding site. The active site cleft
alone is limited in extent and could not easily accommo-
date more than a total of four to five nucleotides.
The many studies delineating the features of the active
site cleft and the amino acid residues responsible for
substrate binding and catalysis, both in solution and in the
various crystals that have been analyzed, have been
reviewed by Anfinsen and White (4), Richards and Wyck-
off (5), and by Blackburn and Moore (6). The structure of
the protein has been solved independently by three dif-
ferent laboratories (7-9) and refined using both x-ray and
neutron diffraction data (10, 11). The various complexes
formed between ribonuclease and a range of substrate
analogues and inhibitors as seen in the crystal by difference
Fourier analysis have been recently reviewed (12). In no
case, however, has a substrate analogue greater in size than
two nucleosides with an intervening phosphodiester link-
age, such as UpA or CpG, been investigated by x-ray
analysis while bound to the active site of the enzyme. Such
a study involving longer oligonucleotides is needed to allow
confident description of the path taken by a long, continu-
ous single strand of RNA or DNA when it is engaged by
the protein. Dinucleotides alone are insufficient to allow
deduction of the amino acid residues involved in the
extended binding site, and they do not provide an adequate
explanation for the protection size and number of ion pairs
formed.
We became interested in pancreatic ribonuclease as a
result of our studies on the gene 5 DNA unwinding protein
from bacteriophage fd. RNAse afforded us the opportu-
nity to study a second single-stranded DNA-binding pro-
tein. From studies of these proteins it is our expectation
that the precise atomic interactions by which this class of
proteins recognizes and binds to single strands of DNA will
become apparent. We believe there will be similar mecha-
nisms involved and similar sets of interactions and struc-
tures used. This is evidenced, for example, by our recent
finding of significant topological equivalence between the
gene 5 protein and pancreatic RNAse (13). To achieve
these objectives, however, it is essential to observe protein-
nucleic acid complexes directly, by Fourier analyses. Up to
now we have had only limited success in obtaining isomor-
phous crystalline complexes of the gene 5 protein either by
diffusion of oligonucleotides into preformed native crystals
(14) or by cocrystallizing the gene 5 protein with oligonu-
cleotides (15). We have had more success in obtaining such
complexes using RNAse as the binding protein.
SOLUTION OF THE STRUCTURE
As described elsewhere (16) we have obtained large single
crystals of both ribonuclease A and B complexed with
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d(pA)4 and with d(pA)6. These crystalline complexes do
not involve the association of a single tetramer of d(pA)4
with the protein, but multiple copies of the oligonucleotide
are bound to each enzyme molecule. We have, more
recently, also obtained crystals of the protein complexed
with the oligomers d(pT)4 and d(pCTTC). Except for a
few percent change in cell dimensions, these are isomor-
phous with the crystals grown from d(pA)4. Given the
pattern established by this sampling of possible lengths and
sequences of oligonucleotides, we believe that an extensive
investigation of subtle binding variations as a function of
length and sequence is possible from the root structure we
present here.
Crystals of pancreatic RNAse complexed with d(pA)4'
like those shown in Fig. I, are of space group P2t2t2t and
have cell dimensions a = 44.56, b = 75.30, and c = 44.60.
A diffraction pattern from one of these crystals is shown in
Fig. 2. Crystals grown using d(pA)6 have dimensions a =
44.50, b = 75.30, C = 43.40. Analogous complexes grown
using RNAse B are of tetragonal space group P41212 (or
P432t 2) and have cell dimensions of a = b = 44.40, C =
156.5. From the cell dimensions and symmetry it is clear
that the two crystal forms are closely related in terms of
packing, which further suggests similarity in the structure
of the protein-nucleic acid complexes. The crystals are all
grown from unbuffered polyethylene glycol 4000 (PEG
4000) solutions by the method of vapor diffusion (17) at
4°C and appear after two days to two weeks. The concen-
tration of PEG varied from 16% wt/vol in the case of the
d(pA)4 crystals to 28% in the case of the d(pA)6 crystals.
These latter crystals were also more difficult to grow.
The details of the structure determination and relevant
statistics regarding both the MIR procedure and refine-
ment of the structure will be presented elsewhere. Here we
FIGURE I A low-power light microscope photograph of crystals of the
complex between ribonuclease A and d(pA). grown from 17% PEG 4000
at 4°C and low ionic strength by the vapor diffusion technique.
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FIGURE 2 A precession x-ray diffraction photograph from a crystal of
the complex formed between ribonuclease A and d(pA)•. The precession
angle is 14° and the x-ray source was an Eliott rotating anode operated at
40 kV and 40 rnA with a focal spot size of 200 Jl2. The reciprocal lattice
level shown is Oklo
shall summarize the general approach and call attention to
certain unanticipated problems that were encountered and
solved. Our procedure was to produce a low-resolution
MIR map of the protein using as few heavy atom deriva-
tives as possible. We then determined the orientation and
position of the known protein molecule in the electron
density map by inspection, placed the atomic structure of
the protein in the unit cell in this optimal orientation, and
refined the protein against the x-ray data (treating it
strictly as a rigid body). Finally we calculated structure
factors and difference Fourier maps to locate the d(pA)4
oligomers. The complex was then refined by least-squares
methods. The application of these procedures was not so
straightforward as one might have expected.
We found it necessary to collect data from five separate
heavy atom derivative compounds to obtain a native Fou-
rier map that eventually could be interpreted in terms of
the known structure of the protein molecule. These heavy
atom compounds included K2PtCI4, UN03, PtBr2(NH3h.
mercury acetate, and K2PtCI6. The data were collected to a
resolution of 3.5 A when crystal stability permitted, which
was not very often. The native crystals were extremely
stable, but except for mercury acetate, all of the crystals
derivitized with heavy atoms deteriorated rapidly. UN03
could be collected only to 5.0 A resolution; mercury acetate
was only weakly substituted, and all of the platinum-
containing derivatives decayed rapidly and were noniso-
morphous beyond low resolution. The most interpretable
map was that computed at 4 A resolution. The average
difference between those phases derived from MIR data
and the phases calculated from the structure at the end of
the 2.5 A refinement was 64.4° to 3.5 A, the limit of the
MIR data.
After several futile attempts using incorrect positions
and orientations (the wrong placements were obvious when
PROTEIN-NUCLEIC ACID AND CHROMATIN STRUCTURES
the rigid body structures were refined at high resolution)
we were able to place the structure correctly in the unit
cell. This was recognized by (a) attainment of a conven-
tional crystallographic R factor of 0.33 first at 5.0 A
resolution using the protein alone; (b) the ability of calcu-
lated phases to return the heavy atom sites clearly in
difference Fourier syntheses; and finally, (c) the attain-
ment of an R factor of 0.32 at 2.8 A after refinement, again
using the unaltered protein structure of Wlodawer and
Sjolin (10) as the model. The electron density map was
complicated to interpret considering the amount of infor-
mation known, but we did not know during the course of
our investigation precisely how much nucleic acid was
present in the asymmetric unit of the crystal. We pro-
ceeded on the assumption that no more than two d(pA)4
oligomers per protein molecule were present, an assump-
tion that turned out to be wrong. We know now that there
are four ordered tetranucleotides present per RNAse mole-
cule and possibly disordered oligomers in the unit cell as
well. Given the substantially greater x-ray scattering
power of the nucleic acid at low resolution and generally
high thermal parameters, we can see now in retrospect that
the low-resolution (4.0 A) electron density map we had
calculated was dominated by images of the DNA frag-
ments. This complicated matters considerably; not only did
we not know the correct number of d(pA)4 oligomers
present, but also the oligomers in many cases contacted
more than one protein molecule in the crystal lattice. The
entire unit cell was extensively cross-linked, and the appar-
ent envelopes seen in the map were not representative of
the features of the protein.
Following correct orientation of the protein molecule
and refinement of the protein as a rigid body at 2.8 A
resolution, difference Fourier maps were calculated to
determine the disposition of the d(pA)4 oligomers. The
packing of the ribonuclease molecules in the orthorhombic
unit cell is shown in Fig. 3. Once again the interpretation of
the maps was not straightforward, partly because we did
not know the number of oligomers present, partly because
only some of the d(pA)4 was clearly recognizable as such;
the rest appeared partially resolved and fragmented. Given
the R factor at this stage, R = 0.32, we might have
expected better. However, if the amount of nucleic acid as
a percentage of nonsolvent weight in the unit cell is
calculated, it comprises almost 25% of the total. Consider-
ing nucleic acid's greater x-ray scattering power, it is
perhaps not so surprising that the image was less than
ideal. It should also be remembered that the RNAse
coordinates of Wlodawer and Sjolin's refinement (10)
provided the phasing model. The differences between that
model and the one we eventually found in this unit cell
could not at this stage be taken into account. Although the
changes are quite small (according to the results of our
refinement the root mean square change in a-earbon
position is 0.36 A), and confined primarily to side chain
atoms and flexible loops, they are significant in terms of
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FIGURE 3 A stereo diagram showing the packing of the protein mole-
cules in the P2,2,2, unit cell of the crystals used in this study. Apparent in
this figure is the scarcity of direct protein-protein contacts in the lattice.
Thus the protein-DNA interactions appear to supply the majority of
stabilizing cross links that are responsible for crystal formation. Please
refer to the color figure section at the back. of this book..
the phases. This was shown by calculation of difference
Fourier maps at the end of refinement using phases based
on the refined protein alone, which produced perceptibly
improved images of the d(pA)4 oligomers as compared
with the starting model.
From the initial difference Fourier maps, two d(pA)4
oligomers could be delineated with confidence. Although
portions of others could also be seen, the connectivity was
not clear, and they were not initially included in the
phasing model. The coordinates of the previously refined
ribonuclease structure (10) were placed appropriately in
the unit cell and refined as a rigid body along with two
tetramers of DNA derived from the difference map. These
were fitted into the unit cell using the graphics program
FRODO (written by A. Jones [18] and modified by B.
Bush) running on an Evans and Sutherland multipicture
system. The procedure used for the rigid body refinement
as well as all subsequent refinement described here was the
restrained-constrained least-squares procedure CORELS
written by J. Sussman (19,20). This approach has been
applied successfully in the past to both protein and nucleic
acid structures independently, but so far as we know, not to
complexes of the two. In the initial cycles only the d(pA)4
211
tetramers were permitted to vary according to the
restrained bonds joining the phosphate and nucleoside
portions of each oligomer. Thus there were eight con-
strained, or structurally fixed, groups defining each d(pA)4
fragment. When no significant change was observed in the
coordinates of the two oligomers included in the model,
difference Fourier maps were calculated and portions of
the third and fourth tetramers were introduced into the
refinement. The dihedral angles of the amino acid side
chains were allowed to refine in concert with the d(pA)4
oligomers; new difference Fouriers were computed; and the
third and fourth tetramers were gradually completed. In
the final stages of the refinement, all amino acids were
treated as constrained groups and allowed to refine simul-
taneously with the constrained DNA while the group
temperature factors were refined as well. During the
course of refinement, geometrical constraints were strin-
gently maintained and all shifts were damped to 0.10-0.50
of their calculated values. Nearly 200 cycles of refinement
were required to reach the final R value at 2.5 A of 0.22.
The approach to refinement we used here was perhaps
overly conservative, but the statistics describing the ide-
ality of the final geometrical parameters suggest that the
structure of the complex we eventually obtained is realistic
and does not deviate from the high accuracy of the starting
protein model (10).
DESCRIPTION OF THE STRUCTURE
The asymmetric unit of the crystalline complex of ribonu-
clease A with d(pA)4 is composed of one protein molecule
associated with four tetramers of d(pA)4. The presence of
isolated peaks in difference Fourier maps indicate there
may be additional, disordered fragments of DNA present
in the solvent regions. The complex of protein plus all
oligonucleotides is shown in Figs. 4-6, and the protein with
each of the four d(pA)4 oligomers in turn in Figs. 7-10.
Two of the DNA fragments may be considered entirely
bound by a single protein molecule with no more than their
3' terminal nucleotides engaged in any intermolecular
interaction. They are essentially intramolecular oligomers.
The two tetramers appearing less clearly in the difference
FIGURE 4 Stereo diagram of the asymmetric unit of the crystalline
complex between ribonuclease A and d(pA). consisting of one protein
molecule associated with four individual d(pA). oligomers. The bonds of
the oligonucleotides have been overdrawn for clarity.
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FIGURE 5 Stereo diagram of the ribonuclease A protein molecule
associated with the four different d(pA). oligonucleotides that comprise
the asymmetric unit of the crystal. Running more or less from the top of
the figure to the bottom in a consistent 3' to 5' direction. the four
fragments of DNA can be seen to trace out an essentially continuous path
through the active site cleft of the enzyme and over the surface of the
protein. Electrostatic linkages are made between phosphates on the
oligonucleotides and lysines 7. 41. 66. 37. 31. 98 as well as with arginines
85.39. and possibly 33. Interactions involving the ribose and base moieties
occur in the active site cleft.
FIGURE 6 Stereo photograph of a van der Waals sphere representation
of the RNAse protein molecule associated with four oligomers of d(pA).
as seen in a similar orientation as in Fig. 5. Please refer to the color figure
section at the back of this book.
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FIGURE 10 In this stereo diagram, the RNAse molecule is seen a~
ciated with the last of the four d(pA). oligomers. This tetramer is secured
at its 5' terminal phosphate by a salt bridge to lysine 98 and extends over
the surface of the protein, possibly making an electrostatic interaction
with arginine 39, and then passes into a large interstitial solvent region.
The 3' terminal nucleotide appears to be in contact with another protein
molecule in the crystal lattice. It is the 5' terminal phosphate of this
tetramer, bound by lysine 98, that is associated as well with the 3' bases of
two other tetramers in the crystal.
only 3.8 Afrom histidine 12, 4.2 A from the amino group
of lysine 41 and 3.7 A from histidine 119, the generally
accepted catalytically important residues in the enzyme.
The base of residue 1 is stacked against the surface of the
protein, as previously observed for other complexes, and
the base is in an anti conformation. The second phosphate
from the active center on this tetramer is 4.7 A from lysine
7, to which it is apparently salt-bridged. The ribose and
base are again packed closely against the protein surface.
The third phosphate from the active center cannot be seen
to make any obvious salt bridges to a lysine or arginine.
The 3' nucleotide is not bound in the crystal by the same
protein molecule as the others in its strand, but makes
limited contact with another d(pA)4 tetramer in the lattice.
While the first nucleotide at the 5' end of the oligomer is in
a fully extended conformation, the same is less true of the
FIGURE 9 A third tetramer of d(pA). is seen here bound to the RNAse
molecule in the absence of all others. It extends from a point very close to
the pyrimidine binding site, though it does not appear to occupy this site,
over the surface of the protein and into a solvent region of the crystal
running 3'-5'. The most 3' phosphate group could be salt-bridged to lysine
66 and others to arginines 85 and 39. After passing through solvent, the 5'
phosphate may be salt-bridged to lysine I of another protein molecule in
the lattice.
FIGURE 8 The tetramer of d(pA). fanhest from the active site of the
enzyme is shown here associated with RNAse in the absence of all other
DNA tetramers. It binds securely through its 5' terminal and penultimate
phosphate groups to the strongly electropositive anion binding site formed
by the clustering of Iysines 31, 91, and 37 as well as arginine 33 on the
underside of the protein molecule. The nucleotides forming the 3' half of
the oligomer follow the contours of the protein and end near the 5'
phosphate of the last d(pA). segment in the set (that shown in Fig. 10)
bound by this same RNAse molecule. The 3' nucleotide of the tetramer
seen in Fig. 7, but from a symmetry equivalent d(pA). in the lattice, is
also near this phosphate creating an apparent DNA-DNA interaction
involving two 3' terminal bases and a 5' terminal phosphate. Thus the
crystal apparently uses DNA-DNA, protein-DNA and protein-protein
interactions to maintain its integrity.
FIGURE 7 The RNAse protein is seen here associated with an oligomer
of d(pA). that enters the active site of the enzyme 3' to 5', occupies the
known purine binding site with the 5' terminal adenosine and is fixed
immediately adjacent to histidines 12 and 119, which are catalytic
residues, by a salt bridge to lysine 41 at the catalytic center. The
disposition of the 5' nucleotide portion of this d(pA). oligomer is similar to
if not the same as the purine residues of dinucleotides previously
visualized in difference Fourier studies of RNAse.
Fouriers and requiring cautious reconstruction during the
refinement process, are, in part, intermolecularly bound.
The two intramolecular oligomers were resolved in
difference Fourier maps, refined without difficulty, and
are characterized by relatively low temperature factors.
One of the d(pA)4 tetramers, seen isolated in Fig. 7, lies in
the active site cleft of the enzyme, as might have been
predicted from the previous x-ray diffraction studies
involving dinucleotide substrate analogues (21-25). The 5'
terminal phosphate of this tetramer is at the active center
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other nucleotides in the strand. It is noteworthy that the
consecutive bases form a roughly stacked array as they fan
out toward the 3' terminus.
The overall conformation of the oligomer bound in the
active site cleft is similar to the chain conformation one
might expect of single-stranded DNA, and it appears to be
consistent with the prediction of Jensen and von Hippel (2)
based on spectroscopic data. We also note that the thermal
parameters of the phosphates of the oligomer bound at the
active site are about the same as the overall temperature
factor for the protein itself, suggesting that immobilization
of the nucleic acid occurs.
The second tetramer to be found entirely by a single
protein molecule is not found at the active site, or even near
the active site, but on the opposite side of the protein
molecule, as seen in Fig. 8. This mode of binding is not
unexpected, however, and might have been predicted from
the results of Matthew and Richards (26, 27). In calcu-
lating the electrostatic field in the volume of space around
a molecule of RNAse under low ionic strength conditions,
they discovered the presence of a very electropositive cavity
in the midst of the cluster of basic amino acids comprised
of lysine 31,37, and 91 along with arginine 33. Indeed, it is
in the center of this cluster that the bulk of the second
d(pA)4 oligomer is bound, and it seems clear that at least
the 5' terminus as well as the penultimate phosphate of this
oligomer form electrostatic linkages to amino acid side
chains, with the most likely participants being Iysines 31
(3.1 A, 91 (3.2 A), and probably 37 (-6 A).
The phosphates of this second tetramer are tucked
closely against the protein surface while the bases of all of
the nucleotides are exposed to the solvent. The entire
oligomer is in an extended conformation. Figs. 4, 5, 6, and
8 show that the 3' terminal nucleotides of this oligomer
extend into a solvent region between protein molecules and
this might seem contrary to its distinct appearance in
difference Fourier maps. However, the 3' terminal nucleo-
tide seems to be involved in a bonding interaction involving
the 3' terminus of a second d(pA)4 oligomer together with
the 5' phosphate of a third d(pA)4 oligomer bound to the
same protein molecule. That is, it appears to be fixed in the
crystal by an inter/intramolecular DNA interaction.
The third tetramer, seen in Fig. 9, has its 3' terminal
nucleotide abutting the pyrimidine binding site of the
enzyme, and though the 3' ribose is only a few angstroms
from the 5' phosphate of the oligomer bound at the active
site, the 3' terminal nucleotide does not appear to occupy
the pyrimidine site. Lysine 66 is 3.4 A from the 3'
phosphate of this oligomer. Arginine 85, which appears to
shift the position of its side chain toward this tetramer, is
likely to aid in positioning the 3' end. The d(pA)4 strand
runs 3'-5' over the surface of the protein passing near
arginine 39 which could form electrostatic linkages with
phosphates of this oligomer. The two nucleotides compris-
ing the 3' end of the tetramer are somewhat compressed
and the bases stacked. As the DNA crosses the surface of
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the protein, it assumes a more extended conformation and
then passes through a solvent region to terminate with its 5'
phosphate -5 A from the amino terminal lysine I of
another protein molecule in the crystal lattice, where it too
is likely fixed by an electrostatic interaction.
The fourth tetramer, seen in Fig. 10, is anchored at its 5'
end by a salt bridge to lysine 98 (4.1 A). This particular
phosphate group of the tetramer has a low temperature
factor and was, from the first difference Fourier, one of the
most clearly defined in the structure. It is this phosphate
that is involved in the apparent DNA-DNA interaction
noted above. From the 5' terminus the oligomer passes in
more or less extended conformation up the side of the
protein very near to arginine 39, where it could form
another ion pair and then extends out into a large solvent
cavity, becoming the most ill-defined of the d(pA)4 oligo-
mers. The 3' phosphate group lies less than 4 A from lysine
91 of another molecule in the unit cell.
While it appears reasonably safe at this stage to describe
in detail the first two tetramers, those bound most securely
to a single protein molecule, some of the characteristics of
the second pair of d(pA)4 tetramers should be regarded
with caution. Their elusive images in the difference elec-
tron density maps suggest some degree of disorder. The
positions of the bases in the solvent regions are unresolved
in the difference maps and it would be unwise at this stage
to attempt a detailed description of their conformations
and the interactions they make. Even so, these two inter-
molecular oligomers appear important to the integrity of
the crystal, because they supply the electrostatic cross-
links that bind the protein molecules, which (as seen in Fig.
4), make only limited protein-protein contacts.
The Bonding Interactions
It seems fairly clear from inspection of the protein plus
d(pA)4 arrangement described above that association
between RNAse and nucleic acid involves predominantly
electrostatic bonding between the lysine, and to a less
obvious extent the arginine, residues, and the negatively
charged phosphates of the polynucleotide chain. Lysines 7,
31, 37, 41, 66, 91, and 98 are all seen engaged in such
interactions, and lysine I is possibly involved in an intermo-
lecular salt cross-bridge. Arginines 39 and 85 are involved
in such ion pairs as well. The protein-nucleic acid interac-
tions are not limited entirely to electrostatic bonds. In this
structure we can see close contact of two nucleotides with
amino acid residues in the active site cleft and these involve
ribose and adenine moieties. From other studies, we can be
certain that at least one additional ribose and base are
bound by the pyrimidine binding site which is, in this
complex, unoccupied. The failure of the DNA fragment to
use this binding mode apparently is a consequence of the
absence of a pyrimidine in the oligonucleotides. Combina-
tion of the two kinds of chemical interactions in the
proportions seen here agrees with the data and predictions
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of Jensen and von Hippel (2), who described just such an
arrangement from their solution studies, for the case of an
extended single strand of DNA. They suggested that the
bulk of the binding would derive from electrostatic bonds
and that the specificity for the enzyme would be provided
by a limited set of interactions directly at the active site
involving the sugar and base portions of the nucleic acid.
Binding of a Single Strand of DNA
A question that must be addressed is whether the complex
seen here in the crystal resembles the complex between
protein and single-stranded DNA that forms in solution, or
whether it is primarily a consequence of nonspecific bind-
ing and the influence of lattice interactions. Clearly, the
crystalline complex between RNAse and d(pA)4 is not an
exact replica of the single-stranded DNA interaction. The
nucleic acid chain is not continuous but composed of four
segments; the pyrimidine binding site is unfilled because
there are no pyrimidine residues; and some of the observed
interactions occur between protein molecules and reflect
lattice interactions. Yet, there are a number of reasons to
believe that the complex we observe here does mimic the
complex formed with single stranded nucleic acid in solu-
tion. If those electrostatic interactions that form between
the d(pA)4 tetramers and only a single RNAse molecule
are considered, and if the nucleotides involved in intermo-
lecular interactions are ignored, then the series of nucleo-
tides remaining trace out a near-continuous path running
from the 3' terminus of the oligomer bound in the active
site cleft, through the active site, over the surface of the
protein, and finally into the electropositive cluster on the
back side of the protein. This is shown in Fig. 11. The path
would require between 11 and 13 total nucleotides and
would use all of the interactions described previously. The
distances between phosphate groups would be stereochemi-
cally reasonable and no dramatic turns or bends would be
required. The course of the nucleotides would be 3' to 5'
over the entire path so no reversal in polarity occurs for any
oligomer.
While the model described here is consistent with the
binding of a continuous single strand of DNA, one may ask
if there is any evidence that this path is in fact the one
actually used by the DNA. We believe that there is such
evidence. Jensen and von Hippel (2) have shown the
protection, or site-covering size, to be 8-12 nucleotides
long when the protein binds to single-stranded DNA.
Clearly the active site cleft alone is inadequate to explain
this feature. The model presented here, based on the
d(pA)4 fragments, requires -12 nucleotides along the
polynucleotide chain. These would be in more or less
extended conformation, as predicted from Jensen and von
Hippel's data. Record et aL (3) determined by salt titration
that seven to eight ion pairs are formed between the protein
and the DNA over its course. The model presented here in
fact contains interactions between six lysine residues and
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FIGURE II Stereo diagram of the four oligomers of d(pA). showing
their relative disposition in space in the absence of the protein molecule. If
the binding interactions between the DNA fragments and the protein are
mapped on the surface of the ribonuclease, they trace out a near
continuous path from the 3' terminus of the first to the 5' terminus of the
last. The path is particularly evident if those nucleotides are ignored that
are responsible for intermolecular cross-links, and only those considered
that are reasonably grouped with a single protein molecule.
possibly two to three arginine side chains, numbers consis-
tent with their results. The distribution of the kinds of
interactions in this complex is also consistent with the
distribution involving phosphates and ribosides predicted
by Jensen and von Hippel (2) and are consistent with the
findings of Karpel et aL (28) using nucleic acid analogues
lacking heterocyclic bases.
As further evidence that this may resemble a specific
complex, the first tetramer involved occupies the active site
cleft and uses some interactions previously seen in x-ray
diffraction studies of dinucleotide complexes and many of
those predicted on the basis of solution studies. These
include, for example, the involvement of lysines 7, 41, and
66 with phosphate groups. The thermal parameters for this
oligomer, as well as for the elements of all the other
oligomers bound directly by the RNAse, are as low as
those for the protein. The 5' phosphate group is fixed by
lysine 41 with histidines 12 and 119 nearby, as would be
expected from previous studies. No substantial changes in
the protein were required to accommodate these interac-
tions and the backbone conformation of the protein is
virtually unchanged. At the 5' end of the path is another
oligomer that was consistently clear and is apparently
firmly bound by the protein molecule. This oligomer has its
5' and penultimate phosphate nearly buried in the center of
the electropositive cavity lying on the back side of the
RNAse molecule and predicted by Matthew and Richards
to be a strong anion binding site (26, 27).
The distribution of basic amino acid residues on the
protein capable of forming electrostatic interactions with a
negatively charged polynucleotide chain is not random, as
is evidenced by this complex between RNAse and d(pA)4.
215
The lysine and arginine groups are in fact presented in a
linear array over the surface of the molecule so that they
are spatially complementary to the arrangement of phos-
phate groups along the course of a polynucleotide chain, or
in this case the segments of a chain. Thus one function of
the structure of ribonuclease A may be to place basic
chemical groups in three-dimensional space so that they
guide the single-stranded nucleic acid molecule through
the active site cleft in an energy efficient manner that does
not perturb, but is in fact consistent with, the natural
conformational preferences of the RNA or DNA.
Because the crystals of this protein-nucleic acid com-
plex were grown at low ionic strength and the observed
interactions are predominantly electrostatic, it might be
suggested that they are fortuitous and would not be present
at the higher salt concentrations that would be found under
more physiological conditions. As Record et al. (3) have
argued, however, it is the mixing entropy of released bound
ions displaced by the structurally constrained nucleic acid
that drives the formation of the RNAse and DNA com-
plex. The energy change derived from the Coulombic
interactions is not of primary importance. Record's inter-
pretation of Jensen and von Hippel's data in this regard is
convincing. The interactions seen in this complex would
not necessarily be absent or appreciably different under
conditions of more physiologically relevant ionic environ-
ment.
Finally, if the d(pA)4 oligomer bound in the active site
cleft and the oligomer that appears to emerge from the
pyrimidine binding site are considered alone as an essen-
tially continuous strand of eight nucleotides, they seem to
describe an arc, seen in Fig. 12, of roughly constant radius.
This arc is similar to that assumed by a single strand of
nucleic acid when a part of a DNA or RNA helical duplex.
Further, if the remaining two oligomers are considered in
the same way, they too form a similar kind of arc, seen in
Fig. 13, though not quite so well defined as in the first case.
Perhaps these arcs, resembling helical turns, simply reflect
FIGURE 12 Stereo diagram of the d(pA). oligomers seen in Figs. 7 and
9 that more or less use the active site cleft of the ribonuclease molecule.
Evident here is the rather smooth and continuous arc formed by the eight
nucleotides that resembles a turn of helix in native duplex DNA.
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FIGURE 13 Stereo diagram of the d(pA). oligomers seen in Figs. 8 and
10 that use the electropositive anion binding site on the side of the protein
molecule away from the active site. Curiously, these two oligomers also
form a rather smooth and continuous arc of nucleotides similar to that
created by the other pair of d(pA). tetramers seen in Fig. 12.
the conformational affinities of nucleic acid strands, or
perhaps they imply certain mechanistic features of the
protein-nucleic acid complex as it forms under physiolog-
ical conditions. We hope the significance of these arcs will
become clearer as these studies progress.
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McPHERSON: No, although there are DNA-DNA interactions in these
crystals. The complex is not maintained strictly by protein-DNA con-
tacts. There are substantial protein-protein contacts, and there are also
some DNA-DNA interactions. These involve, for example, a 5' phos-
phate group that is bound to lysine 91, plus two bases from two other
tetramers. We think it is the amino groups of the adenines that are
hydrogen-bonding to the phosphate groups at the 5' of another DNA
tetramer. Thus protein-protein, nucleic acid-nucleic acid, and protein-
nucleic acid interactions all hold the crystal together.
MAKOWSKI: What interactions are there between the protein and the
bases?
McPHERSON: The bases appear to be engaged only at the active site,
and those are essentially the same interactions that were observed by
crystallographers working with dinucleotide complexes of ribonuclease.
A pyrimidine is inserted into the deep pocket of the P site on the ribonu-
clease, and the adenosine base is packed against the surface of the
protein at the A site. Those are the only two bases that are closely bound
by protein. The other bases are turned away from the protein, with the
phosphates tucked in close to the surface, in contact with the lysines and
arginines. It is primarily an electrostatic complex, with little dependence
on hydrophobic interactions.
217
WICKSTROM: Have you tried crystallizing ribonuclease with the dode-
canucleotide to make sure that your virtual DNA strand is not an arti-
fact?
McPHERSON: We're attempting that. We've set up many crystal trials.
We can vary the sequence to anyone of many sequences. We can also
vary the length. For example, we've already solved this complex with
d(pA)6, so we know what the hexamer does. The problem with using a
dodecamer is that to get it to bind like the virtual strand we need a
pyrimidine in the sequence, to fill the pyrimidine site. The adenines
won't occupy the pyrimidine site; we'd have to use d(pT)12' for exam-
ple. We've attempted crystallization with oligomers of eight and 12
bases, as well as the tetramers and hexamers, and we've obtained micro-
crystals in nearly every case, but we have not yet obtained crystals
suitable for diffraction from the long oligomers.
WICKSTROM: Do crystals of ribonuclease with the hexamer resemble
those you got with the tetramer?
McPHERSON: They were isomorphous, in the sense that the unit cell
and symmetry were the same. There was an 18% residual difference
between the d(pA)6 and the d(pA)4 crystals. The protein is in the identi-
cal position. That's what provided phasing, which is why we could solve
other complexes very rapidly; we just inserted the protein in its known
position. When we did that with d(pA)6, the protein was essentially the
same, but many of the DNA-oligomer interactions were quite different.
There was a much more complex arrangement. With 24 nucleotides
associated with each protein molecule there were more intermolecular
nucleotides. The helical filaments look quite different: there are long-
period helical filaments, but they are not nearly so pronounced as in the
d(pA)4 complex. When we use longer oligomers we get a substantial
modification of the DNA distribution in the unit cell. This is in part a
result of the fact that the protein only allows the nucleic acid a certain
amount of space in the unit cell, and the nucleic acid must accommodate
itself to the available space as well as to the interactions on the protein.
MOORE: Have the base-stacking interactions along the strand been lost?
McPHERSON: Yes. A lot of them have been lost because the DNA must
fit into the available space allowed by the crystal. The protein deter-
mines the basic cell size and symmetry.
MOORE: So you would expect that base stacking in a real substrate
would also be lost?
McPHERSON: Ye§, especially at the active site. We did idealize the
base orientations in the virtual strand. These are not the dispositions
observed in the complex; we imposed the positions to improve its ap-
pearance. We observed some stacking in the crystalline complex, but not
nearly as much as one might expect.
GLITZ: The primary structures of about 40 pancreatic ribonucleases are
now known, mostly from Jaap Beintema. Have you looked at any of
those sequences to see how much conservation there is of the positively
charged residues you see interacting with your oligomer?
McPHERSON: That analysis was done some time ago, but not by us,
and I can't tell you the exact results. You're correct about the number of
sequences. How much preservation of those residues there is, is a good
question.
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MAKOWSKI: One of your paper's referees asks: Why do you consider
an oligodeoxynucleotide containing purines to be a good model for the
catalytically productive interaction of oligoribonucleotides with ribonu-
clease, given the fact that the enzyme is known to be specific for pyrimi-
dine units in RNA?
McPHERSON: The referee is asking whether the DNA single-strand is
like the RNA single-strand that the protein actually degrades and acts
upon catalytically. Almost all spectral studies and competition studies
have shown that DNA binds in almost exactly the same way as a single-
stranded RNA chain. A number of studies in the literature have shown
quite convincingly that that is true. The most extensive study was by von
Hippel and Jensen, who did a tremendous amount of work on the binding
of pancreatic ribonuclease to single-stranded DNA and showed that the
interactions were basically the same.
MAKOWSKI: Another question from the referee: Can you assume that
the conformational preferences of RNA and DNA oligonucleotides are
sufficiently similar that the oligodeoxynucleotide used in this study is, in
fact, a good mimic of the interaction of the enzyme with the RNA?
McPHERSON: Why are we using poly dA instead of pyrimidines when
ribonuclease is known to be specific for pyrimidines? That is a perfectly
legitimate criticism. We started with pA because that is what we hap-
pened to have on hand when we tried to grow our crystals. We got
beautiful crystals and, needless to say, we could not resist going ahead
and solving the structure. The fair criticism is that ribonuclease doesn't
work that well with pA, so we then employed tetramers of deoxy pT in
the crystallization attempts and, though it was more difficult than with
pA, we obtained beautiful crystals with those as well. Because, with
respect to the protein, these crystals were essentially isomorphous with
the d(pA)4 complex, we inserted the protein, and within two days of
obtaining the native data we had a map that showed the positions of the
d(pT)4 tetramers. That structure has just been refined by Stan Kozolak in
our laboratory. The structure appears to have three ordered d(pT)4's in
the structure, rather than four d(pA)4 's. One of the d(pT)4's extends into
the binding cleft of the protein, just as one d(pA)4 does, except that it is
offset by one nucleotide in the 5' direction because the 5' terminal
pyrimidine is now in the pyrimidine binding site. So the pT goes all the
way through the active site, with the 5' terminal phosphate sticking out.
Now we can see two situations: the d(pT)4 complex, where the pyrimi-
dine binding site is filled, and the d(pA)4 complex, where the 5' phos-
phate is held by lysine 41 and terminates in the active site. It appears that
the phosphate at the site of catalysis may not be at exactly the same site
in the two complexes; it is displaced by an angstrom or two, which is a
large difference. The other phosphates are superimposable in the two
complexes.
RAGHAVENDRA: What is the backbone conformation of the oligonu-
cleotide? Does it conform to any particular conformation, like A, B, C,
or Z?
McPHERSON: No. The backbone is in a very extended conformation.
It is not similar to any of the known forms of DNA. However, the
conformation of single-stranded DNA is very difficult to define because
it has so many conformational possibilities available to it. A refinement
program has not yet been written that will properly refine single-
stranded DNA simultaneously with protein. We're using Joel Sussman's
CORELS program, which is about as good as there is. But there are so
many energy minima available to single-stranded DNA that unless you
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start very close to the correct conformation from your electron density
maps, I'm not sure that you're going to end up in exactly the right
conformation.
MAKOWSKI: How far apart are the phosphates?
McPHERSON: They vary from - 5 to 6.5 A.
CHANDRASEKARAN: It is very difficult to say what kind of confor-
mation single-stranded DNA would take on. If the phosphorus-phos-
phorus distance is - 6 A, then it can be almost any structure, and you
are finishing with - 72 A for 12 nucleotides. That means the bases
could be apart by as much as 6 A, if you follow a helical path. This
might not be the energetically most favorable conformation, but it is
interacting with a protein. Until you have the high-resolution data, it is
going to be difficult to see more about the structure. However, it is
encouraging to know the kind of interactions that it can have, particu-
larly the arginines and Iysines interacting with the phosphates.
BURNETT: How well can you see the DNA? Do the bases have high
temperature factors?
McPHERSON: The nucleotides that occur at the active site have thermal
parameters no higher than the average for the protein. The phosphate
groups that are directly bound by lysine or arginine have equally reason-
able temperature factors. The nucleotides that extend through solvent
are very poorly ordered, and have high temperature factors of - 50-60.
Thus, portions of the DNA that are making bonds with the protein or
with other DNA have fairly low temperature factors, and are clear on the
difference map; the intermolecular portions of DNA are very poorly
defined.
BURNETT: Is that why the bases in the solvent region were drawn with
idealized stacking?
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McPHERSON: That's right.
HENDRICKSON: In the d(pA)6 complex, are there pieces that span the
junctures between nucleotides that occur in the d(pA)4 complex?
McPHERSON: No, but in the d(pT)4 structure there are some.
HENDRICKSON: In the active site tetramer, or in other tetramers as
well?
McPHERSON: Certainly in the active site, because the tetramer is ad-
vanced one position along the chain, so the gap that occurs in the d(pA)4
complex between the first tetramer and the second tetramer is spanned
by the first tetramer of the d(pT)4 complex. We also see a gap jump near
lysine 91. We don't see gap fills in the d(pA)6 structure.
BAYLEY: Is there evidence from solution studies for the affinity of these
small oligomers for ribonuclease? Can you show the stoichiometric
binding of up to four oligomers?
McPHERSON: To my knowledge, no one has studied that.
BAYLEY: Could you hazard a guess as to the relative affinities of the
oligonucleotides?
McPHERSON: The ones that go to the active site probably have very
good affinity, because they make a lot of lysine-phosphate contacts and
they have the hydrophobic interactions at the active site. My guess is that
the affinities for the others would not be very high. I would, by the way,
encourage anyone who sees this as an attractive system for their own
techniques to apply them. We're doing crystallography, but little more
than that on these systems.
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